Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo

Diabetes

Volumn 62, Issue 8, 2013, Pages 2699-2708

  Tessari, Paolo ^a   Cecchet, Diego ^a   Artusi, Carlo ^a   Vettore, Monica ^a   Millioni, Renato ^a   Plebani, Mario ^a   Puricelli, Lucia ^a   Vedovato, Monica ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 N N DIMETHYLARGININE; CREATININE; GLUCOSE; INSULIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; UNCLASSIFIED DRUG; ARGININE; GLUCOSE BLOOD LEVEL; N,N-DIMETHYLARGININE; DRUG DERIVATIVE; N,N DIMETHYLARGININE;

ADULT; AGE; AGED; AGING; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYNTHESIS; YOUNG ADULT; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; BLOOD PRESSURE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ADULT; AGE FACTORS; AGED; ARGININE; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 84884584429     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1127     Document Type: Article

References (49)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012
2. Rush JW, Denniss SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol 2005;30:442-474
3. Torregrossa AC, Aranke M, Bryan NS. Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol 2011;8:230-242
4. Stehouver CD, Henry RM, Dekker JM, Nijpels G, Heine RJ, Bouter LM. Microalbuminuria is associated with impaired endothelium dependent, flow mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction-the Hoorn Study. Kidney Int 2004;92:S42-S44
5. Tessari P, Cecchet D, Cosma A, et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 2010;59:2152- 2159
6. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997;349:837-842
7. Perticone F, Sciacqua A, Maio R, et al. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol 2010;142: 236-241
8. Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002;33:1026-1036
9. Francois M, Kojda G. Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway. Neurochem Int 2004;45:955-961
10. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728
11. Sibal L, Agarwal SC, Home PD, Boger RH. The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev 2010;6:82-90
12. Leiper J, Nandi M. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov 2011;10:277-291
13. Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 2003;107:1891-1895
14. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-491
15. Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003;3:279-288
16. Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc Res 2011;89:516-524
17. Lastra G, Dhuper S, Johnson MS, Sowers Jr. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system. Nat Rev Cardiol 2010;7: 577-584
18. Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med 2005;10 (Suppl. 1):S35-S43
19. Yki-Järvinen H. Action of insulin on glucose metabolism in vivo. Baillieres Clin Endocrinol Metab 1993;7:903-927
20. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138
21. Wolfe RR. Radioactive and stable isotope tracers in biomedicine. In Principles and Practice of Kinetic Analysis. New York, Wiley-Liss, 1992, p. 49-85
22. Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application. Clin Chim Acta 2010;411:1632-1636
23. Pie JE, Baek SY, Kim HP, et al. Age-related decline of inducible nitric oxide synthase gene expression in primary cultured rat hepatocytes. Mol Cells 2002;13:399-406
24. Berkowitz DE, White R, Li D, et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003;108:2000-2006
25. van der Loo B, Labugger R, Skepper JN, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000;192:1731-1744
26. Taddei S, Virdis A, Ghiadoni L, et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001;38:274-279
27. Ceylan-Isik AF, Ari N, Stefek M, et al. Effects of a long-term treatment with an antioxidant pyridoindole on vascular responsiveness in diabetesinduced aging rats. Curr Aging Sci 2011;4:150-157
28. Pierce GL, Jablonski KL, Walker AE, et al. Tetrahydrobiopterin supplementation enhances carotid artery compliance in healthy older men: a pilot study. Am J Hypertens 2012;25:1050-1054
29. Cubeddu LX, Hoffmann IS. Insulin resistance and upper-normal glucose levels in hypertension: a review. J Hum Hypertens 2002;16(Suppl. 1):S52- S55
30. Sasaki A, Doi S, Mizutani S, Azuma H. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol 2007;292:L1480-L1487
31. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-2551
32. Abhary S, Kasmeridis N, Burdon KP, et al. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. Diabetes Care 2009;32:2084-2086
33. Chan NN, Chan JC. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 2002;45:1609-1616
34. Kashyap SR, Roman LJ, Lamont J, et al. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab 2005;90:1100-1105
35. Zhang H, Dellsperger KC, Zhang C. The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update. Basic Res Cardiol 2012;107:237
36. Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008;57:56-63
37. Luzi L, Petrides AS, De Fronzo RA. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 1993;42:1868- 1877
38. Marliss EB, Chevalier S, Gougeon R, et al. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 2006;49:351-359
39. Fukagawa NK, Minaker KL, Rowe JW, Matthews DE, Bier DM, Young VR. Glucose and amino acid metabolism in aging man: differential effects of insulin. Metabolism 1988;37:371-377
40. Kiwanuka E, Coracina A, Vettore M, et al. Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin. Nutr Metab Cardiovasc Dis 2009;19:789-796
41. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulinresistant state. J Cardiovasc Pharmacol 1990;15(Suppl. 5):S18-S25
42. Galvan AQ, Santoro D, Natali A, et al. Insulin sensitivity in familial hypercholesterolemia. Metabolism 1993;42:1359-1364
43. Higashino H, Miya H, Mukai H, Miya Y. Serum nitric oxide metabolite (NO (x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls. Clin Exp Pharmacol Physiol 2007;34:725-731
44. McCarty MF. Optimizing endothelial nitric oxide activity may slow endothelial aging. Med Hypotheses 2004;63:719-723
45. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996;27:849-853
46. Fabian E, Bogner M, Elmadfa I. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors. Eur J Clin Invest 2012;42:42-48
47. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Correlates of arterial stiffness in an ageing population: role of asymmetric dimethylarginine. Pharmacol Res 2009;60:503-507
48. Arrigoni F, Ahmetaj B, Leiper J. The biology and therapeutic potential of the DDAH/ADMA pathway. Curr Pharm Des 2010;16:4089-4102
49. Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP. Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 2008;28:692-697